Definitely, we’re already seeing the research releases on microbots.
A famed futurist who foresees a day when and human and artificial intelligence merge and nanobots battle disease spoke to CBC’s Duncan McCue about what lies ahead.
Category: biotech/medical – Page 2769
Archelis–Wearable Chair
Posted in biotech/medical, wearables
Wearable Chair is now A THING that helps surgeons through long hours of surgery. Actually, much more can be done.”
Nanoinjector Device
Posted in biotech/medical
A lot of folks who know me well; knows that I donate my time and expertise to help with the various cancer foundations such as the National Esophageal Cancer Foundation. Esophageal Cancer is one form of cancer not often caught in time due to its symptoms. However, researchers have developed a 3D Stent that is simply amazing and is bringing a lot of hope for so many. Technology and medicine together is an amazing team.
I cannot wait to share this with the foundation’s president; she lost her husband only 2 years ago to this deadly cancer, I lost a cousin, and 2 years ago doctor’s removed a lesion from my esophagus. I cannot express enough to folks (especially younger folks; this is truly a silent killer and it hits all ages (20s, 30s, 40s, and 50s). And, once you ever have a lesion or cancer; you must be diligent in your follow ups no matter what.
Pretty much everyone I know, myself included, has lost someone to cancer, many of them far too young. Finding a cure for cancer is the lofty, ultimate goal for medical researchers, and people like to fantasize about the day when the headline suddenly appears in the paper: “Cure for Cancer Found!” No more deaths from the disease, no more painful, drawn-out treatments – just a shot or a pill that can eliminate cancer as easily as clearing up an ear infection.
In reality, will it happen like that? It probably won’t be that easy – cancer is a complicated beast, and there are so many different forms with their own unique complexities that a universal, one-off cure is a difficult proposition. However, a lot of promising recent developments do point to a near future in which treatment is much more effective and deaths much more rare. And a lot of those developments involve 3D printing.
Virtual Healthcare & IMSHealth is a major player in this service offering. Healthcare and clinic in your own home.
The University of Southern California Center for Body Computing has teamed with 8 partners to launch a Virtual Care Clinic. The idea with VCC is to create an integrated approach to the use of mobile apps, “virtual” doctors, artificial intelligence, data collection and analysis, as well as diagnostics and wearable sensors to create truly on-demand healthcare.
The partners involved in this effort are peer-reviewed clinical trial database startup Doctor Evidence, drug data resource IMS Health ($IMS), consumer design firm Karten Design, HIPAA-compliant cloud platform Medable, video creator Planet Grande, sensor-enabled pill startup Proteus Digital Health and vision player VSP Global.
VSP’s next-gen sensor-embedded eyewear prototype, dubbed Project Genesis, will be refined and tested at the VCC in consultation with USC CBC, which is the digital health innovation accelerator at Keck School of Medicine. The VCC will also involve USC’s Institute of Creative Technologies (ICT).
What drove David Sengeh to create a more comfortable prosthetic limb? He grew up in Sierra Leone, and too many of the people he loves are missing limbs after the brutal civil war there. When he noticed that people who had prosthetics weren’t actually wearing them, he set out to discover why — and to solve the problem with his team from the MIT Media Lab.
TEDTalks is a daily video podcast of the best talks and performances from the TED Conference, where the world’s leading thinkers and doers give the talk of their lives in 18 minutes (or less). Look for talks on Technology, Entertainment and Design — plus science, business, global issues, the arts and much more.
Find closed captions and translated subtitles in many languages at http://www.ted.com/translate
Follow TED news on Twitter: http://www.twitter.com/tednews
Research is edging us closer to a cure for type 1 diabetes, with encapsulated insulin producing cells that could last for years — ending daily injections
Over 400,000 in the UK alone live with type 1 diabetes, and daily injections are far from a ‘cure’ for the condition. Although these have saved millions worldwide, they’re inaccurate in comparison to the body’s own finely tuned insulin producing cells. This leads to progressive damage and complications.
The wonders of cell therapy
In type 1, and some later stage type 2 diabetics, the body lacks capable insulin producing beta cells. These carefully release packets of insulin in response to fluctuating blood sugar levels, and keep your blood sugar in check. Harvesting beta cells from deceased donors has been attempted in the past, but they’re quickly attacked by the immune system and patients must take unpleasant immunosuppressant drugs alongside the treatment.
Cancer is a mysterious disease for many reasons. Chief among the unknowns are how and why tumors form.
Two University of Iowa studies offer key insights by recording in real time, and in 3-D, the movements of cancerous human breast tissue cells. It’s believed to be the first time cancer cells’ motion and accretion into tumors has been continuously tracked. (See accompanying videos.)
The team discovered that cancerous cells actively recruit healthy cells into tumors by extending a cable of sorts to grab their neighbors—both cancerous and healthy—and reel them in. Moreover, the Iowa researchers report that as little as five percent of cancerous cells are needed to form the tumors, a ratio that heretofore had been unknown.
An international team of researchers has developed a new algorithm that could one day help scientists reprogram cells to plug any kind of gap in the human body. The computer code model, called Mogrify, is designed to make the process of creating pluripotent stem cells much quicker and more straightforward than ever before.
A pluripotent stem cell is one that has the potential to become any type of specialised cell in the body: eye tissue, or a neural cell, or cells to build a heart. In theory, that would open up the potential for doctors to regrow limbs, make organs to order, and patch up the human body in all kinds of ways that aren’t currently possible.
It was Japanese researcher Shinya Yamanaka who first reprogrammed cells in this way back in 2007 — it later earned him a Nobel Prize — but Yamanaka’s work involved a lot of labourious trial and error, and the process he followed is not an easy one to reproduce. Mogrify aims to compute the required set of factors to change cells instead, and it’s passed its early tests with flying colours.